Home › Borstkanker › Californië › San Diego
Borstkanker klinische studies in San Diego, CA
41 studies voor Borstkanker zoeken deelnemers op locaties in en rond San Diego (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
RekruterenFase 3
- University of California San Diego Moores Cancer Center, San Diego
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruterenFase 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
RekruterenFase 3
- Sharp Rees Stealy Medical Group Inc, San Diego
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
RekruterenFase 1
- University of California San Diego Moores Cancer Center, San Diego
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RekruterenFase 1/2
- Sharp Memorial Hospital, San Diego
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
RekruterenFase 2
- California Protons Cancer Therapy Center, San Diego
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
RekruterenFase 3
- California Protons Cancer Therapy Center, San Diego
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
RekruterenFase 2
- UC San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
RekruterenFase 3
- Clinical Trial Site, La Jolla · 11 mijl verwijderd
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
RekruterenFase 3
- Moores Cancer Center, La Jolla · 11 mijl verwijderd
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
RekruterenGezonde vrijwilligers welkom
- University of California San Diego, San Diego
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
RekruterenFase 3
- University Of California - San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
RekruterenFase 3
- UC San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
RekruterenFase 1/2
- University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla · 11 mijl verwijderd
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Scripps Health, San Diego
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruterenFase 1
- UCSD Moores Cancer Center, La Jolla · 11 mijl verwijderd
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
RekruterenFase 1/2
- University of California San Diego Medical Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruterenFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mijl verwijderd
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
RekruterenFase 1/2
- University of California-San Diego, La Jolla · 11 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RekruterenFase 3
- Scripps Health, La Jolla · 11 mijl verwijderd
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekruterenFase 3
- UC San Diego, San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RekruterenFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
RekruterenObservatieonderzoek
- University of California, San Diego, San Diego
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
RekruterenFase 3
- Kaiser Permanente-Rio San Diego, San Diego
- Kaiser Permanente-San Diego Zion, San Diego
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
RekruterenGezonde vrijwilligers welkom
- University of California, San Diego, La Jolla · 11 mijl verwijderd
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
RekruterenFase 1
- UC San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
RekruterenFase 2
- Scripps Health, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
RekruterenFase 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 mijl verwijderd
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
RekruterenFase 1
- University of California, San Diego, La Jolla · 11 mijl verwijderd
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
RekruterenFase 3
- University of California San Diego - Moores Cancer Center, La Jolla · 11 mijl verwijderd
E-Mindfulness Approaches for Living After Breast Cancer
RekruterenFase 3
- Kaiser Permanente-San Diego Zion, San Diego
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruterenFase 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RekruterenFase 1
- Investigative Site #101, La Jolla · 11 mijl verwijderd
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
RekruterenFase 2
- University of California San Diego, La Jolla · 11 mijl verwijderd
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
RekruterenFase 1/2
- SHARP Healthcare, San Diego
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
RekruterenFase 2
- University of California, San Diego, La Jolla · 11 mijl verwijderd
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
RekruterenFase 1/2
- Research Site, La Jolla · 11 mijl verwijderd
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Rekruteren
- UC San Diego Health, La Jolla · 11 mijl verwijderd
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
Rekruteren
- University of California, San Diego, La Jolla · 11 mijl verwijderd
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, La Jolla · 11 mijl verwijderd
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
RekruterenFase 1
- University of California-San Diego, San Diego
Borstkanker studies in andere steden
- New York City, NY136 studies
- Houston, TX126 studies
- Boston, MA112 studies
- Nashville, TN81 studies
- Los Angeles, CA73 studies
- Edison, NJ68 studies
- St. Louis, MO64 studies
- Queens, NY64 studies
- Durham, NC64 studies
- Chicago, IL59 studies
- Philadelphia, PA56 studies
- Dallas, TX55 studies
Andere studies in San Diego
- Niet-kleincellige longkanker48 studies
- Kanker (alle vormen)32 studies
- Prostaatkanker31 studies
- Metastatische kanker30 studies
- Colorectale kanker25 studies
- Eierstokkanker24 studies
- Aldermeesklierkanker24 studies
- Longkanker23 studies
- Obesitas23 studies
- Hartfalen23 studies
- Depressie21 studies
- Melanoom18 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.